Jafron Biomedical Co.,Ltd. (300529.SZ) SHZ

21.35

-0.31(-1.43%)

Updated at October 20 09:26AM

Currency In CNY

Valuation

Market Cap22.92B
Enterprise Value22.39B
P/E Ratio24.64
PEG Ratio-2.52
Price/Sales Ratio7
Price/Book Ratio5.19
Enterprise/Revenue7.19
Enterprise/EBITDA19.22

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.28
Operating Margin0.37

Management Effectiveness

Return On Assets0.12
Return On Equity0.2

Income Statement

Revenue2.68B
Revenue/Share3.04
Gross Profit2.16B
EBITDA1.12B
Net Income820.2M
Diluted EPS1.05

Balance Sheet

Total Cash2.19B
Total Cash/Share2.87
Total Debt1.2B
Total Debt/Equity0.38
Current Ratio3.56
Book Value Per Share4.09

Price History

52-Week Change-34.36
52-Week High34.68
52-Week Low20.73
Moving Average 50 Days23
Moving Average 200 Days23.83

Statistics

Average Volume9.89M
Shares Outstanding762.88M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.8
Trailing Annual Dividend Yield3.77
Payout Ratio0.99
Last Split Factor19:10
Last Split DateMay 20, 2020